Diluted HEPS increased by 22.1% y-y to 51.4cps.
Revenue from continuing ops increased by 8.2% y-y (Volumes: +3.2%, Price mix: +5.0%) to R12 329m.
Gross profit margin from continuing ops up by 40bps to 22.0%, due to disciplined raw material procurement, enhanced capacity utilisation, strategic pricing, and rigorous cost management.
Operating margin from continuing ops up by 170bps to 2.8%, benefitting from lower impairments.
Operating expenses from continuing ops increased by 9.8% y-y, with operating expense to revenue of 17.6% (FY24: 17.3%).
Dividend of 28.0cps (FY24: 15.0cps).
Cashflow from operations increased by 54.2% y-y to R748m.
Gross debt decreased from R1.5bn to R1.2bn, while net cash increased from R293m to R388m. Net debt to EBITDA decreased from 2.53x to 1.22x.
The results for Denny Mushrooms are disclosed in the group’s discontinued operations for FY25. The comparative prior period statement of comprehensive income has been re-presented to provide a like-for-like comparison.
